A novel series of parenteral cephalosporins exhibiting potent activities against Pseudomonas aeruginosa and other Gram-negative pathogens: synthesis and structure-activity relationships
- PMID: 17723304
- DOI: 10.1016/j.bmc.2007.08.001
A novel series of parenteral cephalosporins exhibiting potent activities against Pseudomonas aeruginosa and other Gram-negative pathogens: synthesis and structure-activity relationships
Abstract
A series of 7beta-[2-(2-aminothiazol-4-yl)-2-(Z)-(carboxymethoxyimino)acetamido]cephalosporins bearing a 1-(substituted)-1H-pyrrolo[3,2-b]pyridinium group at C-3' position was synthesized and their in vitro antibacterial activities against Pseudomonas aeruginosa and other Gram-negative pathogens were evaluated. Among the cephalosporins prepared, 7beta-[2-(2-amino-5-chlorothiazol-4yl)-2(Z)-((S)-1-carboxyethoxyimino)acetamido]cephalosporins (42d) showed potent antibacterial activities against P. aeruginosa and other Gram-negative pathogens including the strains which produce class C beta-lactamase and extended spectrum beta-lactamase (ESBL). These results imply that both the Cl atom on the C-7 aminothiazole moiety and the alpha-substituent at the iminoether moiety are essential for the stability against beta-lactamase and the potent activity against Gram-negative bacteria including P. aeruginosa.
Similar articles
-
A novel series of parenteral cephalosporins exhibiting potent activities against both Pseudomonas aeruginosa and other gram-negative pathogens. Part 2: Synthesis and structure-activity relationships.Bioorg Med Chem. 2008 Feb 15;16(4):1632-47. doi: 10.1016/j.bmc.2007.11.028. Epub 2007 Nov 17. Bioorg Med Chem. 2008. PMID: 18065229
-
New broad-spectrum parenteral cephalosporins exhibiting potent activity against both methicillin-resistant Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa. Part 3: 7beta-[2-(5-Amino-1,2,4-thiadiazol-3-yl)-2-ethoxyiminoacetamido] cephalosporins bearing 4-[3-(aminoalkyl)-ureido]-1-pyridinium at C-3'.Bioorg Med Chem. 2004 Aug 1;12(15):4221-31. doi: 10.1016/j.bmc.2004.05.021. Bioorg Med Chem. 2004. PMID: 15246098
-
New broad-spectrum parenteral cephalosporins exhibiting potent activity against both methicillin-resistant Staphylococcus aureus (MRSA) and Pseudomonas aeruginosa. Part 2: Synthesis and structure-activity relationships in the S-3578 series.Bioorg Med Chem. 2004 Aug 1;12(15):4211-9. doi: 10.1016/j.bmc.2004.05.022. Bioorg Med Chem. 2004. PMID: 15246097
-
Update of cefditoren activity tested against community-acquired pathogens associated with infections of the respiratory tract and skin and skin structures, including recent pharmacodynamic considerations.Diagn Microbiol Infect Dis. 2009 Jun;64(2):202-12. doi: 10.1016/j.diagmicrobio.2009.01.017. Epub 2009 Mar 25. Diagn Microbiol Infect Dis. 2009. PMID: 19321284 Review.
-
[Possibility of drug design of beta-lactam antibiotics effective for multiresistant gram-positive pathogens].Nihon Rinsho. 1997 May;55(5):1261-5. Nihon Rinsho. 1997. PMID: 9155184 Review. Japanese.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous